0001209191-16-091526.txt : 20160114
0001209191-16-091526.hdr.sgml : 20160114
20160114190912
ACCESSION NUMBER: 0001209191-16-091526
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160112
FILED AS OF DATE: 20160114
DATE AS OF CHANGE: 20160114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tobira Therapeutics, Inc.
CENTRAL INDEX KEY: 0001311596
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030422069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 GATEWAY BLVD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-6625
MAIL ADDRESS:
STREET 1: 701 GATEWAY BLVD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Tibira Therapeutics, Inc.
DATE OF NAME CHANGE: 20150506
FORMER COMPANY:
FORMER CONFORMED NAME: Regado Biosciences Inc
DATE OF NAME CHANGE: 20041215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lefebvre Eric
CENTRAL INDEX KEY: 0001614741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35953
FILM NUMBER: 161343853
MAIL ADDRESS:
STREET 1: C/O TOBIRA THERAPEUTICS, INC.
STREET 2: 701 GATEWAY BOULEVARD, #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-12
0
0001311596
Tobira Therapeutics, Inc.
TBRA
0001614741
Lefebvre Eric
C/O TOBIRA THERAPEUTICS, INC.
701 GATEWAY BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Stock Options (right to buy)
7.91
2016-01-12
4
A
0
101000
0.00
A
2026-01-11
Common Stock
101000
101000
D
25,250 shares subject to the stock option shall vest on the first anniversary of the date of grant. The remaining shares vest ratably in equal monthly installments over a three (3) year period following the one (1) year anniversary of the date of grant.
/s/ Brian Savage, attorney-in-fact
2016-01-14